{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:25:43Z","timestamp":1776133543405,"version":"3.50.1"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,9,28]],"date-time":"2024-09-28T00:00:00Z","timestamp":1727481600000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Zhanjiang Science and Technology Project","award":["2019A01027"],"award-info":[{"award-number":["2019A01027"]}]},{"name":"Competitive Project of Financial Special Funds for Science and Technology of Zhanjiang City","award":["2021A05083"],"award-info":[{"award-number":["2021A05083"]}]},{"name":"National Clinical Key Specialty Construction Project"},{"name":"Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-Communicable Diseases","award":["2022B1212030003"],"award-info":[{"award-number":["2022B1212030003"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Patients with minimal change nephrotic syndrome (MCNS) usually experience severe oedema, which can affect the absorption of oral corticosteroid during the first 2\u00a0weeks. We conducted a randomized controlled trial (RCT) to compare the efficacy of intravenous (IV) isovalent methylprednisolone induction followed by oral prednisone therapy with conventional oral prednisone therapy in highly oedematous MCNS patients, aiming to provide a better therapy for MCNS patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A single-centre, open-label, parallel-arm RCT was performed in the Nephrology Department of the Affiliated Hospital of Guangdong Medical University. Patients who met the inclusion criteria were enrolled in our study from May 2015 to October 2020 and were randomized to receive conventional oral steroid or 2\u00a0weeks of IV methylprednisolone followed by oral prednisone.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 117 patients were enrolled and randomly assigned to either the sequential group (n\u00a0=\u00a057) or the oral group (n\u00a0=\u00a060). The total remission rate in the sequential group was higher than in the oral group after treatment for 2\u00a0weeks and 4\u00a0weeks (P\u00a0=\u00a0.032, P\u00a0=\u00a0.027). The complete remission (CR) rate was higher in the sequential group than in the oral group (63.3% versus 41.5%; P\u00a0=\u00a0.031) after treatment for 2\u00a0weeks. The time to achieve CR was shorter in the sequential group than in the oral group, with a statistically significant difference {14.0\u00a0days [95% confidence interval (CI) 13.5\u201314.5] versus 16.0\u00a0days [95% CI 12.7\u201319.3], P\u00a0=\u00a0.024}. There were no significant differences in relapse rate (24.5% versus 28.3%; P\u00a0=\u00a0.823) and time to relapse (155\u00a0\u00b1\u00a0103\u00a0days versus 150.7\u00a0\u00b1\u00a0103.7\u00a0days; P\u00a0=\u00a0.916) between two groups.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This study suggested that highly oedematous MCNS patients who received IV isovalent methylprednisolone induction therapy followed by oral prednisone achieved earlier remission than the conventional oral prednisone regimen without differences in relapse rates or adverse effects. Short-term IV methylprednisolone followed by oral prednisone may be a better choice for MCNS patients with severe oedema.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ndt\/gfae208","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T22:01:56Z","timestamp":1727474516000},"page":"731-738","source":"Crossref","is-referenced-by-count":1,"title":["Intravenous methylprednisolone for nephrotic syndrome with minimal change lesions: a randomized controlled trial"],"prefix":"10.1093","volume":"40","author":[{"given":"Jinxia","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Nephrology, National Clinical Key Specialty Construction Program (2023); Institute of Nephrology; Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases; Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City; Affiliated Hospital of Guangdong Medical , Zhanjiang, Guangdong ,","place":["People\u2019s Republic of China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruting","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Boai hospital of Zhongshan, Zhongshan Women and Children's hospital, Affiliated Hospital of Southern Medical University , Zhongshan ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Affiliated Hospital of Nantong University , Nantong ,","place":["People\u2019s Republic of China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianyu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Nephrology Department, Dongguan People's Hospital Affiliated to Southern Medical University , Dongguan ,","place":["People\u2019s Republic of China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongzhi","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, National Clinical Key Specialty Construction Program (2023); Institute of Nephrology; Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases; Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City; Affiliated Hospital of Guangdong Medical , Zhanjiang, Guangdong ,","place":["People\u2019s Republic of China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuiwei","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, National Clinical Key Specialty Construction Program (2023); Institute of Nephrology; Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases; Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City; Affiliated Hospital of Guangdong Medical , Zhanjiang, Guangdong ,","place":["People\u2019s Republic of China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huafeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, National Clinical Key Specialty Construction Program (2023); Institute of Nephrology; Guangdong Provincial Key Laboratory of Autophagy and Major Chronic Non-communicable Diseases; Key Laboratory of Prevention and Management of Chronic Kidney Disease of Zhanjiang City; Affiliated Hospital of Guangdong Medical , Zhanjiang, Guangdong ,","place":["People\u2019s Republic of China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"key":"2025101707315986900_bib1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025101707315986900_bib2","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1681\/ASN.2012070734","article-title":"The treatment of minimal change disease in adults","volume":"24","author":"Hogan","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2025101707315986900_bib3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0272-6386(97)90485-6","article-title":"Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976\u20131979 and 1995\u20131997","volume":"30","author":"Haas","year":"1997","journal-title":"Am J Kidney Dis"},{"key":"2025101707315986900_bib4","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2215\/CJN.03531006","article-title":"Adult minimal-change disease: clinical characteristics, treatment, and outcomes","volume":"2","author":"Waldman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025101707315986900_bib5","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1053\/j.ajkd.2014.09.022","article-title":"Long-term outcome of biopsy-proven minimal change nephropathy in Chinese adults","volume":"65","author":"Szeto","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"4S","key":"2025101707315986900_bib6","first-page":"S1","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group","year":"2021","journal-title":"Kidney Int"},{"key":"2025101707315986900_bib7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1053\/j.ajkd.2023.02.003","article-title":"KDOQI US commentary on the 2021 KDIGO clinical practice guideline for the management of glomerular diseases","volume":"82","author":"Beck","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"2025101707315986900_bib8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1445-5994.1983.tb04479.x","article-title":"Intravenous methylprednisolone pulse therapy in minimal change nephrotic syndrome","volume":"13","author":"Yeung","year":"1983","journal-title":"Aust N Z J Med"},{"key":"2025101707315986900_bib9","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1136\/bmj.291.6505.1305","article-title":"Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome","volume":"291","author":"Imbasciati","year":"1985","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2025101707315986900_bib10","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1440-1797.2011.01544.x","article-title":"Comparison of the effects of intravenous methylprednisolone pulse versus oral prednisolone therapies on the first attack of minimal-change nephrotic syndrome in adults","volume":"17","author":"Fukudome","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"2025101707315986900_bib11","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.2215\/CJN.12331213","article-title":"Comparison of methylprednisolone plus prednisolone with prednisolone alone as initial treatment in adult-onset minimal change disease: a retrospective cohort study","volume":"9","author":"Shinzawa","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025101707315986900_bib12","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2025101707315986900_bib13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1681\/ASN.2008030287","article-title":"New equations to estimate GFR in children with CKD","volume":"20","author":"Schwartz","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"2025101707315986900_bib14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1136\/bmj.280.6215.685","article-title":"Intravenous methylprednisolone in minimal change nephrotic syndrome","volume":"280","author":"Ponticelli","year":"1980","journal-title":"Br Med J (Clin Res Ed)"},{"key":"2025101707315986900_bib15","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.2169\/internalmedicine.54.3927","article-title":"Enhanced steroid therapy in adult minimal change nephrotic syndrome: a systematic review and meta-analysis","volume":"54","author":"Zhao","year":"2015","journal-title":"Intern Med"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfae208\/60611793\/gfae208.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/40\/4\/731\/60611793\/gfae208.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/article-pdf\/40\/4\/731\/60611793\/gfae208.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T11:32:02Z","timestamp":1760700722000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/40\/4\/731\/7783281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,9,27]]},"published-print":{"date-parts":[[2025,4,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfae208","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,9,27]]}}}